Editorial: Management of peritoneal surface malignancies. (cytoreductive surgery, HIPEC, PIPAC, and beyond)

被引：0
|
作者：
Souadka, Amine [1 ,2 ,3 ]
Bakrin, Naoual [4 ,5 ]
机构：
[1] Univ Mohammed V Rabat, Natl Inst Oncol, Surg Oncol Dept, Rabat, Morocco
[2] Ctr Hosp Univ Ibn Sina, Ctr Invest Clin, Rabat, Morocco
[3] Univ Mohammed V Rabat, Equipe Rech Oncol Transat EROT, Rabat, Morocco
[4] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Dept Surg Oncol, Lyon, France
[5] Claude Bernard Univ Lyon 1, Ctr Innovat Cancerol Lyon CICLY, Lyon, France
来源：
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词：
peritoneal surface malignancies; HIPEC (heated intraperitoneal chemotherapy); cytoreductive surgery (CRS); PIPAC; molecular status;
D O I：
10.3389/fonc.2024.1340737
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative
    Beal, Eliza W.
    Srinivas, Shruthi
    Shen, Chengli
    Kim, Alex
    Johnston, Fabian M.
    Greer, Jonathan
    Abbott, Daniel
    Pokrzywa, Courtney
    Raoof, Mustafa
    Grotz, Travis
    Leiting, Jennifer L.
    Fournier, Keith
    Dineen, Sean P.
    Veerapong, Jula
    Kothari, Anai
    Maduekwe, Ugwuji
    Maithel, Shishir
    Patel, Sameer H.
    Wilson, Gregory C.
    Lambert, Laura
    Abdel-Misih, Sherif R.
    Cloyd, Jordan
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 515 - 516
  • [22] Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative
    Beal, Eliza W.
    Srinivas, Shruthi
    Shen, Chengli
    Kim, Alex
    Johnston, Fabian M.
    Greer, Jonathan
    Abbott, Daniel E.
    Pokrzywa, Courtney
    Raoof, Mustafa
    Grotz, Travis E.
    Leiting, Jennifer L.
    Fournier, Keith
    Dineen, Sean
    Powers, Benjamin
    Veerapong, Jula
    Kothari, Anai
    Maduekew, Ugwuji
    Maithel, Shishir
    Wilson, Gregory C.
    Patel, Sameer H.
    Lambert, Laura
    Abdel-Misih, Sherif
    Cloyd, Jordan M.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (03) : 1840 - 1849
  • [23] Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative
    Eliza W. Beal
    Shruthi Srinivas
    Chengli Shen
    Alex Kim
    Fabian M. Johnston
    Jonathan Greer
    Daniel E. Abbott
    Courtney Pokrzywa
    Mustafa Raoof
    Travis E. Grotz
    Jennifer L. Leiting
    Keith Fournier
    Sean Dineen
    Benjamin Powers
    Jula Veerapong
    Anai Kothari
    Ugwuji Maduekew
    Shishir Maithel
    Gregory C. Wilson
    Sameer H. Patel
    Laura Lambert
    Sherif Abdel-Misih
    Jordan M. Cloyd
    Annals of Surgical Oncology, 2023, 30 (3) : 1840 - 1849
  • [24] Second Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy and Peritoneal Carcinomatosis: Single Institution's Experience
    Wong, J.
    Teo, M.
    Tan, G.
    Tham, C.
    Soo, K.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S109 - S109
  • [25] Treatment of Peritoneal Surface Malignancies by Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Spain: Results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP)
    Manzanedo, Israel
    Pereira, Fernando
    Cascales-Campos, Pedro
    Munoz-Casares, Cristobal
    Asensio, Enrique
    Torres-Melero, Juan
    Prada-Villaverde, Arancha
    Caravaca-Garcia, Iban
    Gutierrez-Calvo, Alberto
    Vaque, Javier
    Ortega, Gloria
    Titos-Garcia, Alberto
    Gonzalez-Sanchez, Laura
    Perez-Viejo, Estibalitz
    Serrano, Angel
    Martinez-Torres, Beatriz
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (11)
  • [26] The Perspectives of Cytoreductive Surgery and HIPEC In the Management of Rare-Unclassified tumours with Peritoneal Metastasis
    Gareer, Wahid Y.
    Akmal, Waleed
    Gawad, Wael
    Abdelmagged, Heshan
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S286 - S286
  • [27] Adoption of cytoreductive surgery in the management of peritoneal malignancies-Global trends
    Sedighim, Shaina
    Khan, Aaqil
    Li, Amy Y.
    Tajik, Fatemeh
    Radhakrishnan, Vinodh K.
    Eng, Oliver
    Turaga, Kiran
    Senthil, Maheswari
    JOURNAL OF SURGICAL ONCOLOGY, 2023, 128 (06) : 1021 - 1031
  • [28] Outcomes of minimal access cytoreductive surgery (M-CRS) and HIPEC/EPIC vs. open cytoreductive surgery (O-CRS) and HIPEC/EPIC in patients with peritoneal surface malignancies: a meta-analysis
    Pawar, Ajinkya
    Warikoo, Vikas
    Salunke, Abhijeet
    Sharma, Mohit
    Pandya, Shashank
    Bhardwaj, Amol
    Ks, Sandeep
    Aaron, Jebin
    PLEURA AND PERITONEUM, 2024, 9 (01) : 1 - 13
  • [29] Hospital readmission rates and risk factors for readmission following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancies
    Dreznik, Yael
    Hoffman, Aviad
    Hamburger, Tamar
    Ben-Yaacou, Almog
    Dux, Yossi
    Jacoby, Harel
    Berger, Yaniv
    Nissan, Aviram
    Gutman, Mordechai
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2018, 16 (05): : 278 - 282
  • [30] Negative pressure wound therapy (NPWT) after cytoreductive surgery (CRS) and intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancies: preliminary report
    Serra, F.
    Sergi, W.
    Spatafora, F.
    De Ruvo, N.
    Farinetti, A.
    Mattioli, A., V
    Brugioni, L.
    Gelmini, R.
    GIORNALE DI CHIRURGIA, 2019, 40 (06): : 578 - 582
12345